Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1039/d0an01609h

http://scihub22266oqcxt.onion/10.1039/d0an01609h
suck pdf from google scholar
32975254!ä!32975254

suck abstract from ncbi


Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
pmid32975254      Analyst 2020 ; 145 (23): 7680-7686
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Detection of the SARS-CoV-2 humanized antibody with paper-based ELISA #MMPMID32975254
  • Kasetsirikul S; Umer M; Soda N; Sreejith KR; Shiddiky MJA; Nguyen NT
  • Analyst 2020[Nov]; 145 (23): 7680-7686 PMID32975254show ga
  • This work reports the development of a rapid, simple and inexpensive colorimetric paper-based assay for the detection of the severe acute respiratory symptom coronavirus 2 (SARS-CoV-2) humanized antibody. The paper device was prepared with lamination for easy sample handling and coated with the recombinant SARS-CoV-2 nucleocapsid antigen. This assay employed a colorimetric reaction, which is followed by horseradish peroxidase (HRP) conjugated detecting antibody in the presence of the 3,3',5,5'-tetramethylbenzidine (TMB) substrate. The colorimetric readout was evaluated and quantified for specificity and sensitivity. The characterization of this assay includes determining the linear regression curve, the limit of detection (LOD), the repeatability, and testing complex biological samples. We found that the LOD of the assay was 9.00 ng muL-1 (0.112 IU mL-1). The relative standard deviation was approximately 10% for a sample number of n = 3. We believe that our proof-of-concept assay has the potential to be developed for clinical screening of the SARS-CoV-2 humanized antibody as a tool to confirm infected active cases or to confirm SARS-CoV-2 immune cases during the process of vaccine development.
  • |*Paper[MESH]
  • |Antibodies, Monoclonal, Humanized/*blood/immunology[MESH]
  • |Antibodies, Viral/*blood/immunology[MESH]
  • |Armoracia/enzymology[MESH]
  • |Benzidines/chemistry[MESH]
  • |COVID-19 Testing/instrumentation/*methods[MESH]
  • |COVID-19/diagnosis[MESH]
  • |Colorimetry/instrumentation/*methods[MESH]
  • |Coronavirus Nucleocapsid Proteins/immunology[MESH]
  • |Enzyme-Linked Immunosorbent Assay/instrumentation/*methods[MESH]
  • |Horseradish Peroxidase/chemistry[MESH]
  • |Humans[MESH]
  • |Limit of Detection[MESH]
  • |Phosphoproteins/immunology[MESH]
  • |Proof of Concept Study[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box